History of anatomical lung resection complicates lung transplantation (LTx). Our aim was to identify indications, intraoperative approach and outcome in these challenging cases in a retrospective multicentre cohort analysis. Members of the ESTS Lung Transplantation Working Group were invited to submit data on patients undergoing LTx after a previous anatomical native lung resection between January 2005 and July 2020. The primary end point was overall survival (Kaplan-Meier estimation). Out of 2690 patients at 7 European centres, 26 (1%) patients (14 males; median age 33 years) underwent LTx after a previous anatomical lung resection. The median time from previous lung resection to LTx was 12 years. The most common indications for lung resec...
Background: Lung transplantation is a definitive therapy for a variety of end stage lung diseases. S...
Late-onset noninfectious pulmonary complications (LONIPCs) affect 6% of allogeneic stem cell transpl...
BACKGROUND: Lung transplantation has been accepted widely as therapy for end-stage pulmonary lymphan...
History of anatomical lung resection complicates lung transplantation (LTx). Our aim was to identify...
OBJECTIVES Lung volume reduction surgery (LVRS) and lung transplantation (LTx) are the treatments o...
Objective: Single-lung transplantation (SLTX) in patients with previous contralateral pneumonectomy ...
Lung Transplantation (LT) is an effective modality of treatment to improve respiratory function for ...
International audienceObjectives: Solid organ transplantation is an accepted treatment for end-stage...
Objective. Patients who underwent previous thoracotomy develop dominant perfusion on the contra late...
ObjectivesLung volume reduction surgery (LVRS) provides palliation and improved quality of life in s...
Late-onset noninfectious pulmonary complications (LONIPCs) affect 6% of allogeneic stem cell transpl...
Late-onset noninfectious pulmonary complications (LONIPCs) affect 6% of allogeneic stem cell transpl...
BACKGROUND: The published experience of lung transplantation (LTX) in acute respiratory distress syn...
International audienceBackground. Lymphangioleiomyomatosis (LAM) is a rare disease, leading in some ...
Background: Lung transplantation is a definitive therapy for a variety of end stage lung diseases. S...
Late-onset noninfectious pulmonary complications (LONIPCs) affect 6% of allogeneic stem cell transpl...
BACKGROUND: Lung transplantation has been accepted widely as therapy for end-stage pulmonary lymphan...
History of anatomical lung resection complicates lung transplantation (LTx). Our aim was to identify...
OBJECTIVES Lung volume reduction surgery (LVRS) and lung transplantation (LTx) are the treatments o...
Objective: Single-lung transplantation (SLTX) in patients with previous contralateral pneumonectomy ...
Lung Transplantation (LT) is an effective modality of treatment to improve respiratory function for ...
International audienceObjectives: Solid organ transplantation is an accepted treatment for end-stage...
Objective. Patients who underwent previous thoracotomy develop dominant perfusion on the contra late...
ObjectivesLung volume reduction surgery (LVRS) provides palliation and improved quality of life in s...
Late-onset noninfectious pulmonary complications (LONIPCs) affect 6% of allogeneic stem cell transpl...
Late-onset noninfectious pulmonary complications (LONIPCs) affect 6% of allogeneic stem cell transpl...
BACKGROUND: The published experience of lung transplantation (LTX) in acute respiratory distress syn...
International audienceBackground. Lymphangioleiomyomatosis (LAM) is a rare disease, leading in some ...
Background: Lung transplantation is a definitive therapy for a variety of end stage lung diseases. S...
Late-onset noninfectious pulmonary complications (LONIPCs) affect 6% of allogeneic stem cell transpl...
BACKGROUND: Lung transplantation has been accepted widely as therapy for end-stage pulmonary lymphan...